
Results
11
Companies which are more than 50% undervalued based on analyst price target.
11 companies
Daiichi Sankyo Company
Market Cap: JP¥4.9t
Manufactures and sells pharmaceutical products in Japan and internationally.
4568
JP¥2,758.00
7D
5.5%
1Y
-12.9%
GNI Group
Market Cap: JP¥189.8b
Engages in the research, development, manufacturing, and sale of pharmaceuticals and biomaterials in Japan, China, and the United States.
2160
JP¥2,885.00
7D
3.5%
1Y
-6.5%
PeptiDream
Market Cap: JP¥133.6b
A biopharmaceutical company, engages in the discovery and development of constrained peptides, small molecules, and peptide-drug conjugate therapeutics.
4587
JP¥1,040.00
7D
-2.5%
1Y
-32.0%
Nxera Pharma
Market Cap: JP¥90.0b
Operates as a biopharmaceutical company, engages in drug discovery and development in Japan, the United States, Germany, Switzerland, Bermuda, the United Kingdom, and internationally.
4565
JP¥972.00
7D
-2.9%
1Y
13.7%
SanBio
Market Cap: JP¥82.4b
Engages in the development, production, and sale of regenerative cell medicines for the central nervous system in Japan and the United States.
4592
JP¥1,055.00
7D
4.7%
1Y
-50.2%
Heartseed
Market Cap: JP¥39.2b
Develops and commercializes iPS cell-derived cardiomyocyte replacement therapy for heart failure.
219A
JP¥1,715.00
7D
8.5%
1Y
-40.9%
Healios K.K
Market Cap: JP¥34.0b
Engages in the research, development, manufacturing, and sale of cell therapy and regenerative medicine products in Japan, Europe, and the United States.
4593
JP¥252.00
7D
-0.8%
1Y
-41.0%
StemRIM
Market Cap: JP¥19.2b
A biotechnology company, researches and develops regeneration-inducing medicine in Japan and internationally.
4599
JP¥307.00
7D
-6.1%
1Y
1.7%
Kidswell Bio
Market Cap: JP¥7.6b
Develops pharmaceutical products for the treatment of pediatric, pediatric, intractable, and Asia-endemic diseases in Japan.
4584
JP¥154.00
7D
10.0%
1Y
-32.2%
Noile-Immune Biotech
Market Cap: JP¥5.6b
Researches and develops CAR-T cells for novel cancer immunotherapies.
4893
JP¥128.00
7D
7.6%
1Y
-24.7%
TMS
Market Cap: JP¥4.8b
Engages in the research and development, manufacture, and sale of drug products, quasi-drugs, drug substances, medical devices, and medical commodities.
4891
JP¥106.00
7D
0%
1Y
-33.3%